Annual Publication Report

Size: px
Start display at page:

Download "Annual Publication Report"

Transcription

1 Annual Publication Report 2009 TABLE OF CONTENTS 2 GRONINGEN INSTITUTE FOR KIDNEY DISEASES GIKD 9 CARDIOVASCULAR CENTER CVC 19 GRONINGEN RESEARCH INSTITUTE FOR ASTHMA AND COPD GRIAC 24 CENTER FOR LIVER, DIGESTIVE AND METABOLIC DISEASES CLDS 31 INSTITUTE FOR TRANSPLANTATION, IMMUNITY AND INFLAMMATION TRIO 46 NORTHERN NETHERLANDS ONCOLOGY CENTER NNOC 63 INSTITUTE FOR BIOPHARMACEUTICALS: DISCOVERY, DESIGN AND DELIVERY BDDD 67 CENTER FOR SYNTHESIS AND ANALYSIS S&A

2 GRONINGEN INSTITUTE FOR KIDNEY DISEASES - GIKD Dissertations Boersma, C. Health Economics of cardiovascular & renal disease prevention. (2009) Damman, K. Cardiorenal interaction in heart failure. (2009) Hillege, H. L., Veldhuisen, D. J., Navis, G. J., and Voors, A. A. de Vries, R. Lipid transfer proteins: consequences for cellular cholesterol efflux and cardiovascular risk in diabetes mellitus. (2009) Wolfenbuttel, B. H. R., Dullaart, R. P. F., and van Tol, A. Koudstaal, L. G. The impact of cerebral injury in donation and transplantation : a central role of the intestine. (2009) Ploeg, R. J., van Goor, H., and Leuvenink, H. G. D. Loef, B. G. Acute kidney injury after cardiac surgery : impact on long-term outcome and target for intervention. (2009) Ebels, T., Navis, G. J., Epema, A. H., and Stegeman, C. A. Meijering, B. D. M. Ultrasound and microbubble targeted delivery : exploring the mechanism and its therapeutic potential. (2009) Henning, R. H., van Gilst, W. H., and Deelman, L. E. Melenhorst, W. B. W. H. The biology of ADAMs in renal disease. (2009) van Goor, H. and Visser, L. Rook, M. Living kidney donor safety : insights & outcome. (2009) Navis, G. J., Ploeg, R. J., van Goor, H., van Son, W. J., and Homan van der Heide, J. J. Sanders, J. S. F. Disease-activity in ANCA-associated vasculitis. (2009) Kallenberg, C. G. M. and Stegeman, C. A. Ulu, N. Vascular function in chronic end-organ damage : pharmacological characterization of vasomotor function in systemic vasculature. (2009) Henning, R. H., van Gilst, W. H., Buikema, H., and Schoemaker, R. G. van der Toorn, M. Cigarette smoke-induced mitochondrial dysfunction and oxidative stress in. (2009) Kauffman, H. F., Gans, R. O. B., Koëter, G. H., Slebos, D. J., and Bakker, S. J. L. van Ree, R. M. Chronic low-grade inflammation in renal transplantation. (2009) Gans, R. O. B., Bakker, S. J. L., van Son, W. J., and Homan van der Heide, J. J. vom Hagen, F. M. Experimental models of retinal angiogenesis : the effect of angiopoietin-2 and TNFa modulation. (2009) Molema, G., Hammes, H.-P., and Gans, R. O. B. Journal articles Alkhalaf, A., Kleefstra, N., Groenier, K. H., Bakker, S. J. L., Navis, G. J., Bilo, H. J. G. Thiamine in diabetic nephropathy: a novel treatment modality? Diabetologia 52(6): , Bakker, S. J. L., Gansevoort, R. T., de Zeeuw, D. Albuminuria: What can we expect from the determination of nonimmunoreactive albumin? Current Hypertension Reports 11(2): , Bakker, W. W., Henning, R. H., van Son, W. J., van Pampus, M. G., Aarnoudse, J. G., Niezen-Koning, K. E., Borghuis, T., Jongman, R. M., van Goor, H., Poelstra, K., Navis, G., Faas, M. M. Vascular Contraction and Preeclampsia Downregulation of the Angiotensin Receptor 1 by Hemopexin In Vitro. Hypertension 53(6): 959-U127, Boersema, M., Rienstra, H., van den Heuvel, M., van Goor, H., van Luyn, M. J. A., Navis, G. J., Popa, E. R., Hillebrands, J. L. Donor and Recipient Contribution to Transplant Vasculopathy in Chronic Renal Transplant Dysfunction. Transplantation 88(12): , Boersema, M., Rienstra, H., van den Heuvel, M., van Goor, H., van Luyn, M. J. A., Navis, G. J., Popa, E. R., Hillebrands, J. L. Donor and Recipient Contribution to Transplant Vasculopathy in Chronic Renal Transplant Dysfunction. Transplantation 88(12): , Bos, E. M., Leuvenink, H. G. D., Snijder, P. M., Kloosterhuis, N. J., Hillebrands, J. L., Leemans, J. C., Florquin, S., van Goor, H. Hydrogen Sulfide-Induced Hypometabolism Prevents Renal Ischemia/Reperfusion Injury. Journal of the American Society of Nephrology 20(9): , Broekema, M., Harmsen, M. C., Koerts, J. A., van Kooten, T. G., Uges, D. R. A., Petersen, A. H., van Luyn, M. J. A., Navis, G., Popa, E. R. Ciclosporin Does Not Influence Bone Marrow-Derived Cell Differentiation to Myofibroblasts Early after Renal Ischemia/Reperfusion. American Journal of Nephrology 30(1): 73-83, Celie, J. W. A. M., Beelen, R. H. J., van den Born, J. Heparan sulfate proteoglycans in extravasation: assisting leukocyte guidance. Frontiers in Bioscience 14: , 2

3 Chen, C., Liang, W., Jia, J. Y., van Goor, H., Singhal, P. C., Ding, G. H. Aldosterone Induces Apoptosis in Rat Podocytes: Role of PI3- K/Akt and p38mapk Signaling Pathways. Nephron Experimental Nephrology 113(1): E26-E34, Corpeleijn, E., Bakker, S. J. L., Stolk, R. P. Obesity and impaired renal function: potential for lifestyle intervention? European Journal of Epidemiology 24(6): , Damman, K., Jaarsma, T., Voors, A. A., Navis, G., Hillege, H. L., van Veldhuisen, D. J. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). European Journal of Heart Failure 11(9): , Damman, K., van Deursen, V. M., Navis, G., Voors, A. A., van Veldhuisen, D. J., Hillege, H. L. Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease. Journal of the American College of Cardiology 53(7): , Dasselaar, J. J., Slart, R. H. J. A., Knip, M., Pruim, J., Tio, R. A., McIntyre, C. W., de Jong, P. E., Franssen, C. F. M. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrology Dialysis Transplantation 24(2): , de Borst, M. H., Prakash, J., Sandovici, M., Klok, P. A., Hamming, I., Kok, R. J., Navis, G., van Goor, H. c-jun NH2-Terminal Kinase Is Crucially Involved in Renal Tubulo-Interstitial Inflammation. Journal of Pharmacology and Experimental Therapeutics 331(3): , de Jong, P. E., Gansevoort, R. T. Focus on Microalbuminuria to Improve Cardiac and Renal Protection. Nephron Clinical Practice 111(3): C204-C210, de Leeuw, K., Smit, A. J., de Groot, E., van Roon, A. M., Kallenberg, C. G., Bijl, M. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis 206(2): , de Zeeuw, D., Lambers-Heerspink, H. Drug Dosing for Renoprotection: Maybe It's Time for a Drug Efficacy-Safety Score? Journal of the American Society of Nephrology 20(4): , Dobre, D., Nimade, S., de Zeeuw, D. Albuminuria in heart failure: what do we really know? Current Opinion in Cardiology 24(2): , Dobre, D., Heerspink, H. J. L., de Zeeuw, D. Reducing cardiovascular risk: protecting the kidney. European Heart Journal Supplements 11(F): F39-F46, Doorenbos, C. R. C., van den Born, J., Navis, G., de Borst, M. H. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nature Reviews Nephrology 5(12): , Dullaart, R. P. F. Comment on high HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. European Journal of Clinical Investigation 39(6): 533, Dullaart, R. P. F., de Vries, R., Sluiter, W. J., Voorbij, H. A. M. High plasma C-reactive protein (CRP) is related to low paraoxonase-i (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Clinical Endocrinology 70(2): , Dullaart, R. P. F., Plomgaard, P., de Vries, R., Dahlback, B., Nielsen, L. B. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness. Clinica Chimica Acta 406(1-2): , Dullaart, R. P. F., de Vries, R., Voorbij, H. A. M., Sluiter, W. J., van Tol, A. Serum paraoxonase-i activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus. European Journal of Clinical Investigation 39(3): , Fabbrini, P., Schilte, M. N., Zareie, M., ter Wee, P. M., Keuning, E. D., Beelen, R. H. J., van den Born, J. Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis. Nephrology Dialysis Transplantation 24(12): , Gansevoort, R. T., Ritz, E. Hermann Senator and albuminuria- 025EFforgotten pioneering work in the 19th century. Nephrology Dialysis Transplantation 24(3): , Gansevoort, R. T., de Jong, P. E. The Case for Using Albuminuria in Staging Chronic Kidney Disease. Journal of the American Society of Nephrology 20(3): , Gerrits, E. G., Smit, A. J., Bilo, H. J. G. AGEs, autofluorescence and renal function. Nephrology Dialysis Transplantation 24(3): , Halbesma, N., Bakker, S. J. L., Jansen, D. F., Stolk, R. P., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T. High Protein Intake Associates with Cardiovascular Events but not with Loss of Renal Function. Journal of the American Society of Nephrology 20(8): , Heerspink, H. J. L., Nauta, F. L., van der Zee, C. P., Brinkman, J. W., Gansevoort, R. T., de Zeeuw, D., Bakker, S. J. L. Alkalinization of urine samples preserves albumin concentrations during prolonged frozen storage in patients with diabetes mellitus. Diabetic Medicine 26(5): , Heerspink, H. J. L., Perkovic, V., de Zeeuw, D. Renal and cardioprotective effects of direct renin inhibition: a systematic literature review. Journal of Hypertension 27(12): , 3

4 Heerspink, H. J. L., Agarwal, R., Coyne, D. W., Parving, H. H., Ritz, E., Remuzzi, G., Audhya, P., Amdahl, M. J., Andress, D. L., Zeeuw, D. The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics. American Journal of Nephrology 30(3): , Heerspink, H. L., Ninomiya, T., Zoungas, S., de Zeeuw, D., Grobbee, D. E., Jardine, M. J., Gallagher, M., Roberts, M. A., Cass, A., Neal, B., Perkovic, V. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 373(9668): , Herman, W. H., Dungan, K. M., Wolffenbuttel, B. H. R., Buse, J. B., Fahrbach, J. L., Jiang, H. H., Martin, S. Racial and Ethnic Differences in Mean Plasma Glucose, Hemoglobin A(1c), and 1,5-Anhydroglucitol in Over 2000 Patients with Type 2 Diabetes. Journal of Clinical Endocrinology & Metabolism 94(5): , Hettema, M. E., Zhang, D., Stienstra, Y., Smit, A. J., Bootsma, H., Kallenberg, C. G. M. No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis. Clinical Rheumatology 28(7): , Jochemsen, B. M., Mulder, D. J., van Doormaal, J. J., Mulder, G., Volmer, M., Graaff, R., Smit, A. J. Relation between food and drinking habits, and skin autofluorescence and intima media thickness in subjects at high cardiovascular risk. Journal of Food and Nutrition Research 48(1): 51-58, Kamilic, J., Lely, A. T., van Goor, H., Buikema, H., Tent, H., Navis, G. J., Korstanje, R. Differential ACE expression among tissues in allele-specific Wistar rat lines. Mammalian Genome 20(3): , Kappelle, P. J. W. H., Zwang, L., Huisman, M. V., Banga, J. D., Sluiter, W. J., linga-thie, G. M., Dullaart, R. P. F. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. Expert Opinion on Therapeutic Targets 13(7): , Koetsier, M., Lutgers, H. L., Smit, A. J., Links, T. P., de Vries, R., Gans, R. O. B., Rakhorst, G., Graaff, R. Skin autofluorescence for the risk assessment of chronic complications in diabetes: a broad excitation range is sufficient. Optics Express 17(2): , Koudstaal, L. G., Ottens, P. J., Uges, D. R. A., Ploeg, R. J., van Goor, H., Leuvenink, H. G. D. Increased Intestinal Permeability in Deceased Brain Dead Rats. Transplantation 88(3): , Kramer, A. B., van Timmeren, M. M., Schuurs, T. A., Vaidya, V. S., Bonventre, J. V., van Goor, H., Navis, G. Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. American Journal of Physiology-Renal Physiology 296(5): F1136-F1145, Krikken, J. A., Waanders, F., linga-thie, G. M., Dikkeschei, L. D., Vogt, L., Navis, G. J., Dullaart, R. P. F. Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in nondiabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin. Expert Opinion on Therapeutic Targets 13(5): , Krikken, J. A., Laverman, G. D., Navis, G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Current Opinion in Nephrology and Hypertension 18(6): , Krikken, J. A., Bakker, S. J. L., Navis, G. J. Role of renal haemodynamics in the renal risks of overweight. Nephrology Dialysis Transplantation 24(6): , Kurth, T., de Jong, P. E., Cook, N. R., Buring, J. E., Ridker, P. M. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. British Medical Journal 339 AR b2392 DI /bmj.b2392 Lambers Heerspink, H. J., Dobre, D., de Zeeuw, D. Does the European clinical trials directive really improve clinical trial approval time? Pharmaceutisch Weekblad 144(38): , Laverman, G. D., Bakker, S. J. L., Navis, G. J. Optimal dosing of reninangiotensin-aldosterone system blockers for renal protection: a solved issue? Diabetologia 52(6): , linga-thie, G. M., van Tol, A., Dullaart, R. P. F. Plasma pre beta-hdl formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 1791(8): , Linssen, G. C. M., Damman, K., Hillege, H. L., Navis, G., van Veldhuisen, D. J., Voors, A. A. Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure. Circulation 120(1): 35-41, Loef, B. G., Epema, A. H., Navis, G., Ebels, T., Stegeman, C. A. Postoperative renal dysfunction and preoperative left ventricular dysfunction predispose patients to increased long-term mortality after coronary artery bypass graft surgery. British Journal of Anaesthesia 102(6): , Logtenberg, S. J., Kleefstra, N., Houweling, S. T., Groenier, K. H., Gans, R. O., van Ballegooie, E., Bilo, H. J. Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes A randomized controlled trial. Diabetes Care 32(8): , 4

5 Logtenberg, S. J. J., Kleefstra, N., Groenier, K. H., Gans, R. O. B., Bilo, H. J. G. Use of Short-Term Real-Time Continuous Glucose Monitoring in Type 1 Diabetes Patients on Continuous Intraperitoneal Insulin Infusion: A Feasibility Study. Diabetes Technology & Therapeutics 11(5): , Lutgers, H. L., Gerrits, E. G., Sluiter, W. J., Ubink-Veltmaat, L. J., Landman, G. W. D., Links, T. P., Gans, R. O. B., Smit, A. J., Bilo, H. J. G. Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10). PLoS ONE 4(8 AR e6817 DI /journal.pone ) Lutgers, H. L., Gerrits, E. G., Graaff, R., Links, T. P., Sluiter, W. J., Gans, R. O., Bilo, H. J., Smit, A. J. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 52(5): , Mahmoodi, B. K., Gansevoort, R. T., Kluin-Nelemans, H. C. Antiphospholipid Syndrome, Microalbuminuria, and Risk of Venous Thromboembolism Reply. JAMA - Journal of the American Medical Association 302(9): , Mahmoodi, B. K., Gansevoort, R. T., Veeger, N. J. G. M., Matthews, A. G., Navis, G., Hillege, H. L., van der Meer, J. Microalbuminuria and Risk of Venous Thromboembolism. JAMA - Journal of the American Medical Association 301(17): , Martens, D. H. J., Rake, J. P., Navis, G., Fidler, V., van Dael, C. M. L., Smit, G. P. A. Renal Function in Glycogen Storage Disease Type I, Natural Course, and Renopreservative Effects of ACE Inhibition. Clinical Journal of the American Society of Nephrology 4(11): , Martens, H. A., Zuurman, M. W., de Lange, A. H. M., Nolte, I. M., van der Steege, G., Navis, G. J., Kallenberg, C. G. M., Seelen, M. A., Bijl, M. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity. Annals of the Rheumatic Diseases 68(5): , Meerwaldt, R., Zeebregts, C. J., Navis, G., Hillebrands, J. L., Lefrandt, J. D., Smit, A. J. Accumulation of Advanced Glycation End Products and Chronic Complications in ESRD Treated by Dialysis. American Journal of Kidney Diseases 53(1): , Meijer, E., Bakker, S. J. L., de Jong, P. E., van der Heide, J. J. H., van Son, W. J., Struck, J., Lems, S. P. M., Gansevoort, R. T. Copeptin, a Surrogate Marker of Vasopressin, Is Associated With Accelerated Renal Function Decline in Renal Transplant Recipients. Transplantation 88(4): , Meijer, E., de Jong, P. E., van der Jagt, E. J., Peters, D. J., Breuning, M. H., Gansevoort, R. T. Hereditary cystinuria: New insights and possible treatments. Nederlands Tijdschrift voor Geneeskunde 153(20): , Meijering, B. D. M., van der Wouden, E. A., Pelgrom, V., Henning, R. H., Sharma, K., Deelman, L. E. TGF-beta Inhibits Ang II-Induced MAPK p44/42 Signaling in Vascular Smooth Muscle Cells by Ang II Type 1 Receptor Downregulation. Journal of Vascular Research 46(5): , Meijering, B. D. M., Juffermans, L. J. M., van Wamel, A., Henning, R. H., Zuhorn, I. S., Emmer, M., Versteilen, A. M. G., Paulus, W. J., van Gilst, W. H., Kooiman, K., de Jong, N., Musters, R. J. P., Deelman, L. E., Kamp, O. Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation. Circulation Research 104(5): 679-U226, Melenhorst, W. B., Visser, L., Timmer, A., van den Heuvel, M. C., Stegeman, C. A., van Goor, H. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? American Journal of Physiology-Renal Physiology 297(3): F781- F790, Muntinghe, F. L. H., Verduijn, M., Zuurman, M. W., Grootendorst, D. C., Carrero, J. J., Qureshi, A. R., Luttropp, K., Nordfors, L., Lindholm, B., Brandenburg, V., Schalling, M., Stenvinkel, P., Boeschoten, E. W., Krediet, R. T., Navis, G., Dekker, F. W. CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients. Journal of the American Society of Nephrology 20(7): , Muntinghe, F. L. H., Gross, S., Bakker, S. J. L., Landman, G. W. D., van der Harst, P., Bilo, H. J. G., Navis, G., Zuurman, M. W. CCR5 Delta 32 genotype is associated with outcome in type 2 diabetes mellitus. Diabetes Research and Clinical Practice 86(2): , Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., Eyheramendy, S., Papadakis, K., Voight, B. F., Scott, L. J., Zhang, F., Farrall, M., Tanaka, T., Wallace, C., Chambers, J. C., Khaw, K. T., Nilsson, P., van der Harst, P., Polidoro, S., Grobbee, D. E., Onland-Moret, N. C., Bots, M. L., Wain, L. V., Elliott, K. S., Teumer, A., Luan, J., Lucas, G., Kuusisto, J., Burton, P. R., Hadley, D., McArdle, W. L., Brown, M., Dominiczak, A., Newhouse, S. J., Samani, N. J., Webster, J., Zeggini, E., Beckmann, J. S., Bergmann, S., Lim, N., Song, K., Vollenweider, P., Waeber, G., Waterworth, D. M., Yuan, X., Groop, L., Orho-Melander, M., Allione, A., Di Gregorio, A., Guarrera, S., Panico, S., Ricceri, F., Romanazzi, V., Sacerdote, C., Vineis, P., Barroso, I., Sandhu, M. S., Luben, R. N., Crawford, G. J., Jousilahti, P., Perola, M., Boehnke, M., Bonnycastle, L. L., Collins, F. S., Jackson, A. U., Mohlke, K. L., Stringham, H. M., Valle, T. T., Willer, C. J., Bergman, R. N., Morken, M. A., Doring, A., Gieger, C., Illig, T., Meitinger, T., Org, E., Pfeufer, A., Wichmann, H. E., Kathiresan, S., Marrugat, J., O'Donnell, C. J., Schwartz, S. M., Siscovick, D. S., Subirana, I., Freimer, N. B., Hartikainen, A. L., McCarthy, M. I., O'Reilly, P. F., Peltonen, L., Pouta, A., de Jong, P. E., Snieder, H., van Gilst, W. H., Clarke, R., Goel, A., Hamsten, A., Peden, J. F., Seedorf, U., Syvanen, A. C., Tognoni, G., Lakatta, E. G., Sanna, S., Scheet, P., Schlessinger, D., Scuteri, A., Dorr, M., Ernst, F., Felix, S. B., Homuth, G., Lorbeer, R., Reffelmann, T., Rettig, R., 5

6 Volker, U., Galan, P., Gut, I. G., Hercberg, S., Lathrop, G. M., Zelenika, D., Deloukas, P., Soranzo, N., Williams, F. M., Zhai, G., Salomaa, V., Laakso, M., Elosua, R., Forouhi, N. G., Volzke, H., Uiterwaal, C. S., van der Schouw, Y. T., Numans, M. E., Matullo, G., Navis, G., Berglund, G., Bingham, S. A., Kooner, J. S., Connell, J. M., Bandinelli, S., Ferrucci, L., Watkins, H., Spector, T. D., Tuomilehto, J., Altshuler, D., Strachan, D. P., Laan, M., Meneton, P., Wareham, N. J., Uda, M., Jarvelin, M. R., Mooser, V., Melander, O., Loos, R. J. F., Elliott, P., Abecasis, G. R., Caulfield, M., Munroe, P. B. Genome-wide association study identifies eight loci associated with blood pressure. Nature Genetics 41(6): , Nienhuis, H. L. A., Westra, J., Smit, A. J., Limburg, P. C., Kallenberg, C. G. M., Bijl, M. AGE and their receptor RAGE in systemic autoimmune diseases: An inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity 42(4): , Nijboer, W. N., Schuurs, T. A., Damman, J., van Goor, H., Vaidya, V. S., van der Heide, J. J. H., Leuvenink, H. G. D., Bonventre, J. V., Ploeg, R. J. Kidney Injury Molecule-1 is an Early Noninvasive Indicator for Donor Brain Death-Induced Injury Prior to Kidney Transplantation. American Journal of Transplantation 9(8): , Ochodnicky, P., Henning, R. H., Buikema, H., Kluppel, A. C. A., van Wattum, M., de Zeeuw, D., van Dokkum, R. P. E. Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damage. Nephrology Dialysis Transplantation 24(2): , Oeseburg, H., Iusuf, D., van der Harst, P., van Gilst, W. H., Henning, R. H., Roks, A. J. M. Bradykinin Protects Against Oxidative Stress-Induced Endothelial Cell Senescence. Hypertension 53(2): , Oterdoom, L. H., de Vries, A. P. J., Gansevoort, R. T., de Jong, P. E., Gans, R. O. B., Bakker, S. J. L. Fasting insulin is a stronger cardiovascular risk factor in women than in men. Atherosclerosis 203(2): , Oterdoom, L. H., de Vries, A. P. J., van Ree, R. M., Gansevoort, R. T., van Son, W. J., van der Heide, J. J. H., Navis, G., de Jong, P. E., Gans, R. O. B., Bakker, S. J. L. N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant Recipients Versus the General Population. Transplantation 87(10): , Oterdoom, L. H., Gansevoort, R. T., Schouten, J. P., de Jong, P. E., Gans, R. O. B., Bakker, S. J. L. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis 207(2): , Parving, H. H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Ghadanfar, M., Weissbach, N., Xiang, Z. H., Armbrecht, J., Pfeffer, M. A. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrology Dialysis Transplantation 24(5): , Perkovic, V., Heerspink, H. L., Ninomiya, T., Cass, A., Neal, B. Blood pressure in dialysis patients-look before we leap reply. Lancet 373(9679): , 6-6- Pfeffer, M. A., Burdmann, E. A., Chen, C. Y., Cooper, M. E., de Zeeuw, D., Eckardt, K. U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., Lewis, E. F., Mcgill, J. B., McMurray, J. J. V., Parfrey, P., Parving, H. H., Remuzzi, G., Singh, A. K., Solomon, S. D., Toto, R. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. New England Journal of Medicine 361(21): , Pfeffer, M. A., Burdmann, E. A., Chen, C. Y., Cooper, M. E., de Zeeuw, D., Eckardt, K. U., Ivanovich, P., Kewalramani, R., Levey, A. S., Lewis, E. F., McGill, J., McMurray, J. J. V., Parfrey, P., Parving, H. H., Remuzzi, G., Singh, A. K., Solomon, S. D., Toto, R., Uno, H. Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases 54(1): 59-69, Piers, L. H., Touw, H. R. W., Gansevoort, R., Franssen, C. F. M., Oudkerk, M., Zijlstra, F., Tio, R. A. Relation of Aortic Valve and Coronary Artery Calcium in Patients With Chronic Kidney Disease to the Stage and Etiology of the Renal Disease. American Journal of Cardiology 103(10): , Plomgaard, P., Dullaart, R. P. F., de Vries, R., Groen, A. K., Dahlback, B., Nielsen, L. B. Apolipoprotein M predicts pre-beta-hdl formation: studies in type 2 diabetic and nondiabetic subjects. Journal of Internal Medicine 266(3): , Postma, M. J., de Zeeuw, D. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Nephrology Dialysis Transplantation 24(10): , Rienstra, H., Boersema, M., Onuta, G., Boer, M. W., Zandvoort, A., van Riezen, M., Rozing, J., van Goor, H., Navis, G. J., Popa, E. R., Hillebrands, J. L. Donor and Recipient Origin of Mesenchymal and Endothelial Cells in Chronic Renal Allograft Remodeling. American Journal of Transplantation 9(3): , Samarska, I. V., van Meurs, M., Buikema, H., Houwertjes, M. C., Wulfert, F. M., Molema, G., Epema, A. H., Henning, R. H. Adjunct Nitrous Oxide Normalizes Vascular Reactivity Changes after Hemorrhagic Shock in Mice under Isoflurane Anesthesia. Anesthesiology 111(3): , Smilde, T. D. J., Damman, K., van der Harst, P., Navis, G., Westenbrink, B. D., Voors, A. A., Boomsma, F., van Veldhuisen, D. J., Hillege, H. L. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clinical Research in Cardiology 98(2): , Tak, L. M., Bakker, S. J. L., Slaets, J. P. J., Rosmalen, J. G. M. Is highsensitive C-reactive protein a biomarker for functional somatic 6

7 symptoms? A population-based study. Brain Behavior and Immunity 23(7): , ter Bogt, N. C. W., Bemelmans, W. J. E., Beltman, F. W., Broer, J., Smit, A. J., van der Meer, K. Preventing Weight Gain One-Year Results of a Randomized Lifestyle Intervention. American Journal of Preventive Medicine 37(4): , Ulu, N., Henning, R. H., Goris, M., Schoeinaker, R. G., van Gilst, W. H. Effects of Ivabradine and Metoprolol on Cardiac Angiogenesis and Endothelial Dysfunction in Rats With Heart Failure. Journal of Cardiovascular Pharmacology 53(1): 9-17, Ulu, N., Schoemaker, R. G., Henning, R. H., Buikema, H., Teerlink, T., Zijlstra, F. J., Bakker, S. J. L., van Gilst, W. H., Navis, G. Proteinuria-Associated Endothelial Dysfunction Is Strain Dependent. American Journal of Nephrology 30(3): , van den Hoven, M. J., Waanders, F., Rops, A. L., Kramer, A. B., van Goor, H., Berden, J. H., Navis, G., van der Vlag, J. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species. Nephrology Dialysis Transplantation 24(9): , van der Velde, M., Halbesma, N., de Charro, F. T., Bakker, S. J. L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T. Screening for Albuminuria Identifies Individuals at Increased Renal Risk. Journal of the American Society of Nephrology 20(4): , van Dokkum, R. P. E., Buikema, H. Possible new druggable targets for the treatment of nephrosis Perhaps we should find them in caveolea? Current Opinion in Pharmacology 9(2): , van Goor, H., Melenhorst, W. B. W. H., Turner, A. J., Holgate, S. T. Adamalysins in biology and disease. Journal of Pathology 219(3): , van Goor, H., Leuvenink, H. G. D. The goddess of the waters. Kidney International 75(8): , van Timmeren, M. M., Lems, S. P. M., Hepkema, B. G., Bakker, S. J. L. Anti-Human Leukocyte Antigen Antibodies and Development of Graft Failure After Renal Transplantation. Transplantation 88(12): , van Timmeren, M. M., Lems, S. P. M., Hepkema, B. G., Bakker, S. J. L. Anti-Human Leukocyte Antigen Antibodies and Development of Graft Failure After Renal Transplantation. Transplantation 88(12): , Vegter, S., Perna, A., Hiddema, W., Ruggenenti, P., Remuzzi, G., Navis, G., Postma, M. J. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism. Pharmacogenetics and Genomics 19(9): , Visser, A., Dijkstra, G. J., Kuiper, D., de Jong, P. E., Franssen, C. F. M., Gansevoort, R. T., Izaks, G. J., Jager, K. J., Reineveld, S. A. Accepting or declining dialysis: Considerations taken into account by elderly patients with end-stage renal disease. Journal of Nephrology 22(6): , Visser, A., Dijkstra, G. J., Kuiper, D., de Jong, P. E., Franssen, C. F. M., Gansevoort, R. T., Izaks, G. J., Jager, K. J., Reijneveld, S. A. Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease. Journal of Nephrology 22(6): , Visser, F. W., Krikken, J. A., Muntinga, J. H. J., Dierckx, R. A., Navis, G. J. Rise in Extracellular Fluid Volume During High Sodium Depends on BMI in Healthy Men. Obesity 17(9): , Vogt, L., de Zeeuw, D., Woittiez, A. J. J., Navis, G. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients. Nephrology Dialysis Transplantation 24(4): , Waanders, F., Vaidya, V. S., van Goor, H., Leuvenink, H., Damman, K., Hamming, I., Bonventre, J. V., Vogt, L., Navis, G. Effect of Renin-Angiotensin-Aidosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled Trial. American Journal of Kidney Diseases 53(1): 16-25, Waanders, F., Rienstra, H., Boer, M. W., Zandvoort, A., Rozing, J., Navis, G., van Goor, H., Hillebrands, J. L. Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats. American Journal of Physiology-Renal Physiology 296(5): F1072-F1079, Westendorp, B., Hamming, I., Szymanski, M. K., Navis, G., van Goor, H., Buikema, H., van Gilst, W. H., Schoemaker, R. G. Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor. European Journal of Pharmacology 602(2-3): , Witte, E. C., Heerspink, H. J. L., de Zeeuw, D., Bakker, S. J. L., de Jong, P. E., Gansevoort, R. First Morning Voids Are More Reliable Than Spot Urine Samples to Assess Microalbuminuria. Journal of the American Society of Nephrology 20(2): , Wolffenbuttel, B. H. R., Klaff, L. J., Bhushan, R., Fahrbach, J. L., Jiang, H., Martin, S. Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents. Diabetic Medicine 26(11): , Wong, L. S., Windt, W. A., Roks, A. J., van Dokkum, R. P., Schoemaker, R. G., de Zeeuw, D., Henning, R. H. Renal failure 7

8 induces telomere shortening in the rat heart. Netherlands Heart Journal 17(5): , Xu, Y., Henning, R. H., Sandovici, M., van der Want, J. J., van Gilst, W. H., Buikema, H. Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT(1)- and epidermal growth factor-receptor function. European Journal of Heart Failure 11(3): , 8

9 CARDIOVASCULAR CENTER -CVC Dissertations Broers, C. J. M. De nurse practitioner: verpleegkundig specialist tussen care en cure. (2009) Veldhuisen, D. J., Jaarsma, T., and Umans, V. A. W. M. Damman, K. Cardiorenal interaction in heart failure. (2009) Hillege, H. L., Veldhuisen, D. J., Navis, G. J., and Voors, A. A. Meijering, B. D. M. Ultrasound and microbubble targeted delivery : exploring the mechanism and its therapeutic potential. (2009) Henning, R. H., van Gilst, W. H., and Deelman, L. E. Piers, L. H. Computed tomography for the evaluation of the aortic valve and coronary arteries. (2009) Zijlstra, F. and Tio, R. Ulu, N. Vascular function in chronic end-organ damage : pharmacological characterization of vasomotor function in systemic vasculature. (2009) Henning, R. H., van Gilst, W. H., Buikema, H., and Schoemaker, R. G. van der Vleuten, P. A. Left ventricular function after STEMI : developments in diagnostics and cell therapy. (2009) Zijlstra, F. and Tio, R. A. Journal articles Buck, S. Optimization of cardiac resynchronization therapy in atrial fibrillation and sinus rhythm. edited by I. C. van Gelder, D. J. Veldhuisen, and A. H. Maass, 2009, Aalberts, J. J. J., Boonstra, P. W., van den Berg, M. P., Waterbolk, T. W. In-hospital mortality and three-year survival after repaired acute type A aortic dissection. Netherlands Heart Journal 17(6): , Ahmed, S., Crijns, H. J. G. M., van Gelder, I. C. Treatment With Amiodarone to Prevent Atrial Fibrillation Reply. JAMA - Journal of the American Medical Association 301(10): 1020, Al-Ansari, S., Zeebregts, C. J., Slart, R. H. J. A., Peppelenbosch, M., Tio, R. A. Galectins in Atherosclerotic Disease. Trends in Cardiovascular Medicine 19(5): , Al Ansari, S., Zeebregts, C. J., Slart, R. H. J. A., Peppelenbosch, M., Tio, R. A. Galectins in Atherosclerotic Disease. Trends in Cardiovascular Medicine 19(5): , Altena, R., Perik, P. J., van Veldhuisen, D. J., de Vries, E. G. E., Gietema, J. A. Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncology 10(4): , Anker, S. D., Voors, A., Okonko, D., Clark, A. L., James, M. K., von Haehling, S., Kjekshus, J., Ponikowski, P., Dickstein, K. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. European Heart Journal 30(11): , Annema, C., Luttik, M. L., Jaarsma, T. Do Patients With Heart Failure Need a Case Manager? Journal of Cardiovascular Nursing 24(2): , Annema, C., Luttik, M. L., Jaarsma, T. Reasons for readmission in heart failure: Perspectives of patients, caregivers, cardiologists, and heart failure nurses. Heart & Lung 38(5): , Backlund, M., Paukku, K., Daviet, L., de Boer, R. A., Valo, E., Hautaniemi, S., Kalkkinen, N., Ehsan, A., Kontula, K. K., Lehtonen, J. Y. A. Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Research 37(7): , Bartels, A. L., Zeebregts, C. J., Bijl, M., Tio, R. A., Slart, R. H. J. A. Fused FDG-PET and MRI imaging of Takayasu arteritis in vertebral arteries. Annals of Nuclear Medicine 23(8): , Beghetti, M., Haworth, S. G., Bonnet, D., Barst, R. J., Acar, P., Fraisse, A., Ivy, D. D., Jais, X., Schulze-Neick, I., Galie, N., Morganti, A., Dingemanse, J., Kusic-Pajic, A., Berger, R. M. F. Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study. British Journal of Clinical Pharmacology 68(6): , Belonje, A. M. S., Westenbrink, B. D., Voors, A. A., von Haehling, S., Ponikowski, P., Anker, S. D., van Veldhuisen, D. J., Dickstein, K. Erythropoietin levels in heart failure after an acute myocardial infarction: Determinants, prognostic value, and the effects of captopril versus losartan. American Heart Journal 157(1): 91-96, Bhuiyan, Z. A., Jongbloed, J. D. H., van der Smagt, J., Lombardi, P. M., Wiesfeld, A. C. P., Nelen, M., Schouten, M., Jongbloed, R., Cox, M. G. P. J., van Wolferen, M., Rodriguez, L. M., van Gelder, I. C., Bikker, H., Suurmeijer, A. J. H., van den Berg, M. P., Mannens, 9

10 M. M. A. M., Hauer, R. N. W., Wilde, A. A. M., van Tintelen, J. P. Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients Results From a Multicenter Study. Circulation- Cardiovascular Genetics 2(5): 418-U22, Bhuiyan, Z. A., Jongbloed, J. D. H., van der Smagt, J., Lombardi, P. M., Wiesfeld, A. C. P., Nelen, M., Schouten, M., Jongbloed, R., Cox, M. G. P. J., van Wolferen, M., Rodriguez, L. M., van Gelder, I. C., Bikker, H., Suurmeijer, A. J. H., van den Berg, M. P., Mannens, M. M. A. M., Hauer, R. N. W., Wilde, A. A. M., van Tintelen, J. P. Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients Results From a Multicenter Study. Circulation-Cardiovascular Genetics 2(5): 418-U22, Broers, C. J. M., Sinclair, N., van der Ploeg, T. J., Jaarsma, T., van Veldhuisen, D. J., Umans, V. A. W. M. The post-infarction nurse practitioner project A prospective study comparing nurse intervention with conventional care in a non-high-risk myocardial infarction population. Netherlands Heart Journal 17(2): 61-67, Brugemann, J., van der Bij, W., Verschuuren, E. A. M., Klungel, A. A., van der Horst, I. C. C., Erasmus, M. E., Kerstjens, H. A. M., van Veldhuisen, D. J., Zijlstra, F. Experience with combined heartlung transplant at the University Medical Center Groningen. Nederlands Tijdschrift voor Geneeskunde 153(27): , Buck, S., Maass, A. H., van Veldhuisen, D. J., van Gelder, I. C. Cardiac resynchronisation therapy and the role of optimal device utilisation. Netherlands Heart Journal 17(9): , Burzotta, F., De Vita, M., Gu, Y. L. L., Isshiki, T., Lefevre, T., Kaltoft, A., Dudek, D., Sardella, G., Orrego, P. S., Antoniucci, D., De Luca, L., Biondi-Zoccai, G. G. L., Crea, F., Zijlstra, F. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. European Heart Journal 30(18): , Carballo, S., Robinson, P., Otway, R., Fatkin, D., Jongbloed, J. D. H., de Jonge, N., Blair, E., van Tintelen, J. P., Redwood, C., Watkins, H. Identification and Functional Characterization of Cardiac Troponin I As a Novel Disease Gene in Autosomal Dominant Dilated Cardiomyopathy. Circulation Research 105(4): 375- U116, Cleland, J. G. F., McMurray, J. J. V., Kjekshus, J., Cornel, J. H., Dunselman, P., Fonseca, C., Hjalmarson, A., Korewicki, J., Lindberg, M., Ranjith, N., van Veldhuisen, D. J., Waagstein, F., Wedel, H., Wikstrand, J. Plasma Concentration of Amino- Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). Journal of the American College of Cardiology 54(20): , Cohen-Solal, A., Kotecha, D., van Veldhuisen, D. J., Babalis, D., Bohm, M., Coats, A. J., Roughton, M., Poole-Wilson, P., Tavazzi, L., Flather, M. Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. European Journal of Heart Failure 11(9): , Cox, M. G. P. J., van der Smagt, J. J., Wilde, A. A. M., Wiesfeld, A. C. P., Atsma, D. E., Nelen, M. R., Rodriguez, L. M., Loh, P., Cramer, M. J., Doevendans, P. A., van Tintelen, J. P., De Bakker, J. M. T., Hauer, R. N. W. New ECG Criteria in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Circulation-Arrhythmia and Electrophysiology 2(5): , Damman, K., Hillege, H. L., van Veldhuisen, D. J. Albuminuria in heart failure: a CHARMing new risk factor? Lancet 374(9689): , Damman, K., Jaarsma, T., Voors, A. A., Navis, G., Hillege, H. L., van Veldhuisen, D. J. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). European Journal of Heart Failure 11(9): , Damman, K., van Veldhuisen, D. J., Hillege, H. L. Cardiac Resynchronization Therapy Improves Renal Function: Importance of Forward and Backward Failure. Journal of Cardiac Failure 15(1): 78-79, Damman, K., van Deursen, V. M., Navis, G., Voors, A. A., van Veldhuisen, D. J., Hillege, H. L. Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease. Journal of the American College of Cardiology 53(7): , Dasselaar, J. J., Slart, R. H. J. A., Knip, M., Pruim, J., Tio, R. A., McIntyre, C. W., de Jong, P. E., Franssen, C. F. M. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrology Dialysis Transplantation 24(2): , de Boer, R. A., Voors, A. A., Muntendam, P., van Gilst, W. H., van Veldhuisen, D. J. Galectin-3: a novel mediator of heart failure development and progression. European Journal of Heart Failure 11(9): , de Boer, R. A., van der Harst, P., van Veldhuisen, D. J., van den Berg, M. P. Pharmacogenetics in heart failure: promises and challenges. Expert Opinion on Pharmacotherapy 10(11): , de Jong, R. M., Tio, R. A., van der Harst, P., Voors, A. A., Koning, P. M., Zeebregts, C. J. A. M., van Veldhuisen, D. J., Dierckx, R. A. J. O., Slart, R. H. J. A. Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with 10

11 idiopathic dilated cardiomyopathy. Journal of Nuclear Cardiology 16(5): , De Smedt, R. H. E., Denig, P., Haaijer-Ruskamp, F. M., Jaarsma, T. Perceived medication adverse effects and coping strategies reported by chronic heart failure patients. International Journal of Clinical Practice 63(2): , de Vries, B. M. W., Hillebrands, J. L., van Dam, G. M., Tio, R. A., de Jong, J. S., Slart, R. H. J. A., Zeebregts, C. J. Multispectral Near- Infrared Fluorescence Molecular Imaging of Matrix Metalloproteinases in a Human Carotid Plaque Using a Matrix- Degrading Metalloproteinase-Sensitive Activatable Fluorescent Probe. Circulation 119(20): E534-E536, Deuling, J. H. H., Smit, M. D., Maass, A. H., van den Heuvel, A. F. M., Nieuwland, W., Zijlstra, F., van Gelder, I. C. The value and limitations of a wound inspection clinic after cardiac device implantation. European Journal of Cardiovascular Nursing 8(4): , Dickinson, M. G., Scholvinck, E. H., Boonstra, A., Vonk- Noordegraaf, A., Snijder, R. J., Berger, R. M. F. Low Complication Rates With Totally Implantable Access Port Use in Epoprostenol Treatment of Pulmonary Hypertension. Journal of Heart and Lung Transplantation 28(3): , Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J. The European cardiac resynchronization therapy survey. European Heart Journal 30(20): , Dieperink, W., Weelink, E. E. M., van der Horst, I. C. C., De Vos, R., Jaarsma, T., Aarts, L. P. H. J., Zijlstra, F., Nijsten, M. W. N. Treatment of presumed acute cardiogenic pulmonary oedema in an ambulance system by nurses using Boussignac continuous positive airway pressure. Emergency Medicine Journal 26(2): , Duffels, M. G. J., van der Plas, M. N., Surie, S., Winter, M. M., Bouma, B. J., Groenink, M., van Dijk, A. P. J., Hoendermis, E. S., Berger, R. M. F., Bresser, P., Mulder, B. J. M. Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism. Netherlands Heart Journal 17(9): 334-+, Duffels, M. G. J., Vis, J. C., van Loon, R. L. E., Berger, R. M. F., Hoendermis, E. S., van Dijk, A. P. J., Bouma, B. J., Mulder, B. J. M. Down patients with Eisenmenger syndrome: Is bosentan treatment an option? International Journal of Cardiology 134(3): , Duffels, M. G. J., Hardziyenka, M., Surie, S., de Bruin-Bon, R. H. A. C., Hoendermis, E. S., van Dijk, A. P. J., Bouma, B. J., Tan, H. L., Berger, R. M. F., Bresser, P., Mulder, B. J. M. Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension. European Journal of Echocardiography 10(3): , Duffels, M. G. J., Vis, J. C., van Loon, R. L. E., Nieuwkerk, P. T., van Dijk, A. P. J., Hoendermis, E. S., de Bruin-Bon, R. H. A. C., Bouma, B. J., Bresser, P., Berger, R. M. F., Mulder, B. J. M. Effect of Bosentan on Exercise Capacity and Quality of Life in Adults With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease With and Without Down's Syndrome. American Journal of Cardiology 103(9): , Fokkema, M. L., Vlaar, P. J., Vogelzang, M., Gu, Y. L., Kampinga, M. A., de Smet, B. J., Jessurun, G. A., Anthonio, R. L., van den Heuvel, A. F., Tan, E. S., Zijlstra, F. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction a randomized controlled trial. Circulation: Cardiovascular Interventions 2(4): , Fokkema, M. L., Vlaar, P. J., Svilaas, T., Vogelzang, M., Amo, D., Diercks, G. F. H., Suurmeijer, A. J. H., Zijlstra, F. Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for STelevation myocardial infarction. European Heart Journal 30(8): , Fokkema, M. L., van der Vleuten, R., Vlaar, P. J., Svilaas, T., Zijlstra, F. Incidence, Predictors, and Outcome of Reinfarction and Stent Thrombosis Within One Year After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. Catheterization and Cardiovascular Interventions 73(5): , Fokkema, M. L., Vlaar, P. J., Zijlstra, F. Response to letter regarding article "effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: A randomized controlled trial". Circulation: Cardiovascular Interventions 2(6): e6, Fokkema, M. L., Vlaar, P. J., Vogelzang, M., Gu, Y. L., Kampinga, M. A., de Smet, B. J., Jessurun, G. A., Anthonio, R. L., van den Heuvel, A. F., Tan, E. S., Zijlstra, F. Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction A Randomized Controlled Trial. Circulation-Cardiovascular Interventions 2(4): , Fokkema, M. L., Vlaar, P. J., Zijlstra, F. Response to Letter Regarding Article "Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial". Circulation-Cardiovascular Interventions 2(6): E6, Ge, D. L., Su, S. Y., Zhu, H. D., Dong, Y. B., Wang, X. L., Harshfield, G. A., Treiber, F. A., Snieder, H. Stress-Induced Sodium Excretion A New Intermediate Phenotype to Study the Early Genetic Etiology of Hypertension? Hypertension 53(2): , 11

12 Geiger, R., Sharma, H. S., Mooi, W. J., Berger, R. M. F. Pulmonary vascular remodeling in congenital heart disease: Enhanced expression of heat shock proteins. Indian Journal of Biochemistry & Biophysics 46(6): , Ghali, J. K., Wikstrand, J., van Veldhuisen, D. J., Fagerberg, B., Goldstein, S., Hjalmarson, A., Johansson, P., Kjekshus, J., Ohlsson, L., Samuelsson, O., Waagstein, F., Wedel, H. The Influence of Renal Function on Clinical Outcome and Response to beta-blockade in Systolic Heart Failure: Insights From Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). Journal of Cardiac Failure 15(4): , Glaudemans, A. W. J. M., Slart, R. H. J. A., Zeebregts, C. J., Veltman, N. C., Tio, R. A., Hazenberg, B. P. C., Dierckx, R. A. J. O. Nuclear imaging in cardiac amyloidosis. European Journal of Nuclear Medicine and Molecular Imaging 36(4): , Groen, J. M., van der Vleuten, P. A., Greuter, M. J. W., Zijlstra, F., Oudkerk, M. Comparison of MRI, 64-slice MDCT and DSCT in assessing functional cardiac parameters of a moving heart phantom. European Radiology 19(3): , Groenveld, H. F., Crijns, H. J. G. M., Rienstra, M., van den Berg, M. P., van Veldhuisen, D. J., van Gelder, I. C. Does intensity of rate control influence outcome in persistent atrial fibrillation?: Data of the RACE study. American Heart Journal 158(5): , Gu, Y. L., Fokkema, M. L., Kampinga, M. A., de Smet, B. J. G. L., Tan, E. S., van den Heuvel, A. F. M., Zijlstra, F. Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration. Trials 10 AR 90 DI / Halbersma, W. B., Arrigoni, S. C., Mecozzi, G., Grandjean, J. G., Kappetein, A. P., van der Palen, J., Zijlstra, F., Mariani, M. A. Four- Year Outcome of OPCAB No-Touch With Total Arterial Y- Graft: Making the Best Treatment a Daily Practice. Annals of Thoracic Surgery 88(3): , Hartog, J. W. L., Willemsen, S., Voors, A. A. Letter by Hartog et al Regarding Article, "Advanced Glycation End Products Accumulate in Vascular Smooth Muscle and Modify Vascular but Not Ventricular Properties in Elderly Hypertensive Canines". Circulation 119(10): E233, Hartong, D. T., Mcgee, T. L., Sandberg, M. A., Berson, E. L., Asselbergs, F. W., van der Harst, P., De Vivo, I., Dryja, T. P. Search for a correlation between telomere length and severity of retinitis pigmentosa due to the dominant rhodopsin Pro23His mutation. Molecular Vision 15(60-62): , Hassan, M. O., Bayoumi, R. A., Lopez-Alvarenga, J. C., Snieder, H., Jaju, D., Al-Yahyaee, S., Al-Hadabi, S., Comuzzie, A. G., Albarwani, S. Heritability of Hemodynamic Reactivity to Laboratory Stressors in a Homogenous Arab Population: 'Oman Family Study'. Twin Research and Human Genetics 12(6): , Hassan, M. O., Bayoumi, R. A., Lopez-Alvarenga, J. C., Snieder, H., Jaju, D., Al Yahyaee, S., Al Hadabi, S., Comuzzie, A. G., Albarwani, S. Heritability of Hemodynamic Reactivity to Laboratory Stressors in a Homogenous Arab Population: 'Oman Family Study'. Twin Research and Human Genetics 12(6): , Hoekstra, M., Vogelzang, M., Verbitskiy, E., Nijsten, M. W. N. Health technology assessment review: Computerized glucose regulation in the intensive care unit - how to create artificial control. Critical Care 13(5 AR 223 DI /cc8023) Holm, P. W., Slart, R. H. J. A., Zeebregts, C. J., Hillebrands, J. L., Tio, R. A. Atherosclerotic plaque development and instability: A dual role for VEGF. Annals of Medicine 41(4): , Huijskes, R. V. H. P., Hoogenberg, K., Wiesfeld, A. C. P., Pijl, M. E. J., van Gelder, I. C. Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report. Netherlands Heart Journal 17(11): , Jaarsma, T., Beattie, J. M., Ryder, M., Rutten, F. H., McDonagh, T., Mohacsi, P., Murray, S. A., Grodzicki, T., Bergh, I., Metra, M., Ekman, I., Angermann, C., Leventhal, M., Pitsis, A., Anker, S. D., Gavazzi, A., Ponikowski, P., Dickstein, K., Delacretaz, E., Blue, L., Strasser, F., McMurray, J. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure 11(5): , Jaarsma, T., Arestedt, K. F., Martensson, J., Dracup, K., Stromberg, A. The European Heart Failure Self-care Behaviour scale revised into a nine-item scale (EHFScB-9): a reliable and valid international instrument. European Journal of Heart Failure 11(1): , Kampinga, M. A., Vlaar, P. J., Fokkema, M. L., Gu, Y. L., Zijlstra, F. Thrombus Aspiration during Percutaneous coronary intervention in Acute non-st-elevation myocardial infarction Study (TAPAS II)-Study design. Netherlands Heart Journal 17(11): , Klapholz, M., Abraham, W. T., Ghali, J. K., Ponikowski, P., Anker, S. D., Knusel, B., Sun, Y., Wasserman, S. M., van Veldhuisen, D. J. The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure. European Journal of Heart Failure 11(11): , Klinkenberg, T. J., Ahmed, S., Ten Hagen, A., Wiesfeld, A. C. P., Tan, E. S., Zijlstra, F., van Gelder, I. C. Feasibility and outcome of epicardial pulmonary vein isolation for lone atrial fibrillation using minimal invasive surgery and high intensity focused ultrasound. Europace 11(12): , 12

13 Lazarenko, S. V., van der Vleuten, P. A., Tio, R. A., Willemsen, A. T. M., Paans, A. M. J., Douma, J. E., Zeebregts, C. J., Dierckx, R. A., Zijlstra, F., Slart, R. H. J. A. Left ventricular volume assessment by planar radionuclide ventriculography evaluated by MRI. Nuclear Medicine Communications 30(9): , Lesman-Leegte, I., van Veldhuisen, D. J., Hillege, H. L., Moser, D., Sanderman, R., Jaarsma, T. Depressive symptoms and outcomes in patients with heart failure: data from the COACH study dagger. European Journal of Heart Failure 11(12): , Lesman-Leegte, I., Jaarsma, T., Coyne, J. C., Hillege, H. L., van Veldhuisen, D. J., Sanderman, R. Quality of Life and Depressive Symptoms in the Elderly: A Comparison Between Patients With Heart Failure and Age- and Gender-Matched Community Controls. Journal of Cardiac Failure 15(1): 17-23, Lexis, C. P. H., Rahel, B. M., Meeder, J. G., Zijlstra, F., van derhorst, I. C. C. The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus. Cardiovascular Diabetology 8 AR 41 DI / Li, Z. B., Snieder, H., Harshfield, G. A., Treiber, F. A., Wang, X. L. A 15-year longitudinal study on ambulatory blood pressure tracking from childhood to early adulthood. Hypertension Research 32(5): , Li, Z. B., Snieder, H., Su, S. Y., Ding, X. H., Thayer, J. F., Treiber, F. A., Wang, X. L. A longitudinal study in youth of heart rate variability at rest and in response to stress. International Journal of Psychophysiology 73(3): , Liem, A., van de Woestijne, A. P., Bruijns, E., van Lennep, H. W. O. R., de Boo, J. A. J., van Halteren, H. K., van Es, T. P., Jukema, J. W., van der Laarse, A., Zwinderman, A. H., van Veldhuisen, D. J. Effect of EPO administration on myocardial infarct size in patients with non-ste acute coronary syndromes; results from a pilot study. International Journal of Cardiology 131(2): , Linssen, G. C. M., Damman, K., Hillege, H. L., Navis, G., van Veldhuisen, D. J., Voors, A. A. Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure. Circulation 120(1): 35-41, Liu, G. F., Riese, H., Spector, T. D., Mangino, M., O'Dell, S. D., Stolk, R. P., Snieder, H. Bivariate genetic modelling of the response to an oral glucose tolerance challenge: A gene x environment interaction approach. Diabetologia 52(6): , Luttik, M. L., Lesman-Leegte, I., Jaarsma, T. Quality of Life and Depressive Symptoms in Heart Failure Patients and Their Partners: The Impact of Role and Gender. Journal of Cardiac Failure 15(7): , Luttik, M. L., Jaarsma, T., Lesman, I., Sanderman, R., Hagedoorn, M. Quality of life in partners of people with congestive heart failure: gender and involvement in care. Journal of Advanced Nursing 65(7): , Maass, A. H., Buck, S., Nieuwland, W., Brugemann, J., van Veldhuisen, D. J., van Gelder, I. C. Importance of Heart Rate During Exercise for Response to Cardiac Resynchronization Therapy. Journal of Cardiovascular Electrophysiology 20(7): , Maass, A. H., Waterbolk, T. W., van Gelder, I. C. Pitfalls of internal cardioverter defibrillator implantation: Part I. Europace 11(2): , Maass, A. H., Waterbolk, T. W., van Gelder, I. C. Pitfalls of internal cardioverter defibrillator implantation: Part II. Europace 11(2): , Mahmoodi, B. K., Gansevoort, R. T., Veeger, N. J. G. M., Matthews, A. G., Navis, G., Hillege, H. L., van der Meer, J. Microalbuminuria and Risk of Venous Thromboembolism. JAMA - Journal of the American Medical Association 301(17): , McMurray, J. J. V., Anand, I. S., Diaz, R., Maggioni, A. P., O'Connor, C., Pfeffer, M. A., Polu, K. R., Solomon, S. D., Sun, Y., Swedberg, K., Tendera, M., van Veldhuisen, D. J., Wasserman, S. M., Young, J. B. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbiditymortality trial. European Journal of Heart Failure 11(8): , Medeiros-Domingo, A., Bhuiyan, Z. A., Tester, D. J., Hofman, N., Bikker, H., van Tintelen, J. P., Mannens, M. M. A. M., Wilde, A. A. M., Ackerman, M. J. The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular Tachycardia or Genotype Negative, Exercise-Induced Long QT Syndrome A Comprehensive Open Reading Frame Mutational Analysis. Journal of the American College of Cardiology 54(22): , Meijering, B. D. M., Juffermans, L. J. M., van Wamel, A., Henning, R. H., Zuhorn, I. S., Emmer, M., Versteilen, A. M. G., Paulus, W. J., van Gilst, W. H., Kooiman, K., de Jong, N., Musters, R. J. P., Deelman, L. E., Kamp, O. Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation. Circulation Research 104(5): 679-U226, Metra, M., Teerlink, J. R., Voors, A. A., Felker, G. M., Milo-Cotter, O., Weatherley, B., Dittrich, H., Cotter, G. Vasodilators in the treatment of acute heart failure: what we know, what we don't. Heart Failure Reviews 14(4): , Moons, P., Fleck, D., Jaarsma, T., Norekval, T. M., Smith, K., Stromberg, A., Thompson, D. R., Budts, W. What do cardiovascular nurses know about the hematological 13

14 management of patients with Eisenmenger syndrome? European Journal of Cardiovascular Nursing 8(4): , Mulder, D. J., van Haelst, P. L., Graaff, R., Gans, R. O., Zijlstra, F., Smit, A. J. Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Netherlands Heart Journal 17(4): , Muntinghe, F. L. H., Gross, S., Bakker, S. J. L., Landman, G. W. D., van der Harst, P., Bilo, H. J. G., Navis, G., Zuurman, M. W. CCR5 Delta 32 genotype is associated with outcome in type 2 diabetes mellitus. Diabetes Research and Clinical Practice 86(2): , Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., Eyheramendy, S., Papadakis, K., Voight, B. F., Scott, L. J., Zhang, F., Farrall, M., Tanaka, T., Wallace, C., Chambers, J. C., Khaw, K. T., Nilsson, P., van der Harst, P., Polidoro, S., Grobbee, D. E., Onland-Moret, N. C., Bots, M. L., Wain, L. V., Elliott, K. S., Teumer, A., Luan, J., Lucas, G., Kuusisto, J., Burton, P. R., Hadley, D., McArdle, W. L., Brown, M., Dominiczak, A., Newhouse, S. J., Samani, N. J., Webster, J., Zeggini, E., Beckmann, J. S., Bergmann, S., Lim, N., Song, K., Vollenweider, P., Waeber, G., Waterworth, D. M., Yuan, X., Groop, L., Orho-Melander, M., Allione, A., Di Gregorio, A., Guarrera, S., Panico, S., Ricceri, F., Romanazzi, V., Sacerdote, C., Vineis, P., Barroso, I., Sandhu, M. S., Luben, R. N., Crawford, G. J., Jousilahti, P., Perola, M., Boehnke, M., Bonnycastle, L. L., Collins, F. S., Jackson, A. U., Mohlke, K. L., Stringham, H. M., Valle, T. T., Willer, C. J., Bergman, R. N., Morken, M. A., Doring, A., Gieger, C., Illig, T., Meitinger, T., Org, E., Pfeufer, A., Wichmann, H. E., Kathiresan, S., Marrugat, J., O'Donnell, C. J., Schwartz, S. M., Siscovick, D. S., Subirana, I., Freimer, N. B., Hartikainen, A. L., McCarthy, M. I., O'Reilly, P. F., Peltonen, L., Pouta, A., de Jong, P. E., Snieder, H., van Gilst, W. H., Clarke, R., Goel, A., Hamsten, A., Peden, J. F., Seedorf, U., Syvanen, A. C., Tognoni, G., Lakatta, E. G., Sanna, S., Scheet, P., Schlessinger, D., Scuteri, A., Dorr, M., Ernst, F., Felix, S. B., Homuth, G., Lorbeer, R., Reffelmann, T., Rettig, R., Volker, U., Galan, P., Gut, I. G., Hercberg, S., Lathrop, G. M., Zelenika, D., Deloukas, P., Soranzo, N., Williams, F. M., Zhai, G., Salomaa, V., Laakso, M., Elosua, R., Forouhi, N. G., Volzke, H., Uiterwaal, C. S., van der Schouw, Y. T., Numans, M. E., Matullo, G., Navis, G., Berglund, G., Bingham, S. A., Kooner, J. S., Connell, J. M., Bandinelli, S., Ferrucci, L., Watkins, H., Spector, T. D., Tuomilehto, J., Altshuler, D., Strachan, D. P., Laan, M., Meneton, P., Wareham, N. J., Uda, M., Jarvelin, M. R., Mooser, V., Melander, O., Loos, R. J. F., Elliott, P., Abecasis, G. R., Caulfield, M., Munroe, P. B. Genome-wide association study identifies eight loci associated with blood pressure. Nature Genetics 41(6): , Nijveldt, R., van der Vleuten, P. A., Hirsch, A., Beek, A. M., Tio, R. A., Tijssen, J. G. P., Piek, J. J., van Rossum, A. C., Zijlstra, F. Early Electrocardiographic Findings and MR Imaging-Verified Microvascular Injury and Myocardial Infarct Size 33. JACC: Cardiovascular Imaging 2(10): , Nolte, I. M., Wallace, C., Newhouse, S. J., Waggott, D., Fu, J. Y., Soranzo, N., Gwilliam, R., Deloukas, P., Savelieva, I., Zheng, D. L., Dalageorgou, C., Farrall, M., Samani, N. J., Connell, J., Brown, M., Dominiczak, A., Lathrop, M., Zeggini, E., Wain, L. V., Newton- Cheh, C., Eijgelsheim, M., Rice, K., de Bakker, P. I. W., Pfeufer, A., Sanna, S., Arking, D. E., Asselbergs, F. W., Spector, T. D., Carter, N. D., Jeffery, S., Tobin, M., Caulfield, M., Snieder, H., Paterson, A. D., Munroe, P. B., Jamshidi, Y. Common Genetic Variation Near the Phospholamban Gene Is Associated with Cardiac Repolarisation: Meta-Analysis of Three Genome-Wide Association Studies. PLoS ONE 4(7 AR e6138 DI /journal.pone ) Nolte, I. M., Wallace, C., Newhouse, S. J., Waggott, D., Fu, J. Y., Soranzo, N., Gwilliam, R., Deloukas, P., Savelieva, I., Zheng, D. L., Dalageorgou, C., Farrall, M., Samani, N. J., Connell, J., Brown, M., Dominiczak, A., Lathrop, M., Zeggini, E., Wain, L. V., Newton- Cheh, C., Eijgelsheim, M., Rice, K., de Bakker, P. I. W., Pfeufer, A., Sanna, S., Arking, D. E., Asselbergs, F. W., Spector, T. D., Carter, N. D., Jeffery, S., Tobin, M., Caulfield, M., Snieder, H., Paterson, A. D., Munroe, P. B., Jamshidi, Y. Common Genetic Variation Near the Phospholamban Gene Is Associated with Cardiac Repolarisation: Meta-Analysis of Three Genome-Wide Association Studies. PLoS ONE 4(7 AR e6138 DI /journal.pone ) Oeseburg, H., Iusuf, D., van der Harst, P., van Gilst, W. H., Henning, R. H., Roks, A. J. M. Bradykinin Protects Against Oxidative Stress- Induced Endothelial Cell Senescence. Hypertension 53(2): , Otterman, M. L., Nijboer, J. M., van der Horst, I. C. C., van Meurs, M., ten Duis, H. J., Nijsten, M. W. N. Reticulocyte Counts and Their Relation to Hemoglobin Levels in Trauma Patients. Journal of Trauma-Injury Infection and Critical Care 67(1): , Peels, J. O. J., Hautvast, R. W. M., de Swart, J. B. R. M., Huybregts, M. A. J. M., Umans, V. A. W. M., Arnold, A. E. R., Jessurun, G. A. J., Zijlstra, F. Percutaneous coronary intervention without on site surgical back-up; two-years registry of a large Dutch community hospital. International Journal of Cardiology 132(1): 59-65, Petrie, C. J., Voors, A. A., van Veldhuisen, D. J. Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients. International Journal of Cardiology 131(3): , Piers, L. H., Touw, H. R. W., Gansevoort, R., Franssen, C. F. M., Oudkerk, M., Zijlstra, F., Tio, R. A. Relation of Aortic Valve and Coronary Artery Calcium in Patients With Chronic Kidney Disease to the Stage and Etiology of the Renal Disease. American Journal of Cardiology 103(10): , Pons, D., Monraats, P. S., Zwinderman, A. H., de Maat, M. P. M., Doevendans, P. A. F. M., de Winter, R. J., Tio, R. A., Waltenberger, J., Jukema, J. W. Metabolic background determines the importance of NOS3 polymorphisms in restenosis after 14

15 percutaneous coronary intervention: A study in patients with and without the metabolic syndrome. Disease Markers 26(2): 75-83, Postema, P. G., van den Berg, M. P., van Tintelen, J. P., van den Heuvel, F., Grundeken, M., Hofman, N., van der Roest, W. P., Nannenberg, E. A., Krapels, I. P. C., Bezzina, C. R., Wilde, A. A. M. Founder mutations in the Netherlands SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide. Netherlands Heart Journal 17(11): , Qian, C., Schoemaker, R. G., van Gilst, W. H., Roks, A. J. M. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function. Clinical Science 116(3-4): , Rasoul, S., Ottervanger, J. P., de Boer, M. J., Dambrink, J. H. E., Hoorntje, J. C. A., Gosselink, A. T. M., Zijlstra, F., Suryapranata, H., van't Hof, A. W. J. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for STelevation myocardial infarction. Coronary Artery Disease 20(6): , Rasoul, S., Ottervanger, J. P., de Boer, M. J., Dambrink, J. H. E., Hoorntje, J. C. A., Gosselink, A. T. M., Zijlstra, F., Suryapranata, H., van 't Hof, A. W. J. Primary percutaneous coronary intervention for ST-elevation myocardial infarction: From clinical trial to clinical practice. International Journal of Cardiology 134(1): , Ruifrok, W. P. T., de Boer, R. A., Iwakura, A., Silver, M., Kusano, K., Tio, R. A., Losordo, D. W. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Vascular Medicine 14(1): 29-36, Savva, J., Maqbool, A., White, H. L., Galloway, S. L., Yuldasheva, N. Y., Ball, S. G., West, R. M., de Boer, R. A., van Veldhuisen, D. J., Balmforth, A. J. Polymorphisms of Adrenoceptors are Not Associated With an Increased Risk of Adverse Event in Heart Failure: A MERIT-HF Substudy. Journal of Cardiac Failure 15(5): , Slart, R. H. J. A., Tio, R. A., Zijlstra, F., Dierckx, R. A. Diagnostic pathway of integrated SPECT/CT for coronary artery disease. European Journal of Nuclear Medicine and Molecular Imaging 36(11): , Smilde, T. D. J., Damman, K., van der Harst, P., Navis, G., Westenbrink, B. D., Voors, A. A., Boomsma, F., van Veldhuisen, D. J., Hillege, H. L. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clinical Research in Cardiology 98(2): , Smilde, T. D. J., van Veldhuisen, D. J., van den Berg, M. P. Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. Clinical Research in Cardiology 98(4): , Smit, J. J. J., van Oeveren, W., Ottervanger, J. P., Slingerland, R. J., Remijn, J. A., Zijlstra, F., van 't Hof, A. W. J. Iron-induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST segment elevation myocardial infarction. European Journal of Clinical Investigation 39(2): , Smit, M. D., van Gelder, I. C. Is inflammation a risk factor for recurrent atrial fibrillation? Europace 11(2): , Smit, M. D., van Gelder, I. C. Valsartan and Recurrent Atrial Fibrillation. New England Journal of Medicine 361(5): 532, Sochalski, J., Jaarsma, T., Krumholz, H. M., Laramee, A., McMurray, J. J. V., Naylor, M. D., Rich, M. W., Riegel, B., Stewart, S. What Works In Chronic Care Management: The Case Of Heart Failure. Health Affairs 28(1): , Stoel, M. G., von Birgelen, C., Zijlstra, F. Aspiration of Embolized Thrombus During Primary Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions 73(6): , Su, S., Lampert, R., Zhao, J., Bremner, J. D., Miller, A., Snieder, H., Lee, F., Khan, D., Goldberg, J., Vaccarino, V. Pleiotropy of C- Reactive Protein Gene Polymorphisms With C-Reactive Protein Levels and Heart Rate Variability in Healthy Male Twins. American Journal of Cardiology 104(12): , Su, S. Y., Miller, A. H., Snieder, H., Bremner, J. D., Ritchie, J., Maisano, C., Jones, L., Murrah, N. V., Goldberg, J., Vaccarino, V. Common Genetic Contributions to Depressive Symptoms and Inflammatory Markers in Middle-Aged Men: The Twins Heart Study. Psychosomatic Medicine 71(2): , Su, S. Y., Zhao, J. Y., Bremner, J. D., Miller, A. H., Tang, W. N., Bouzyk, M., Snieder, H., Novik, O., Afzal, N., Goldberg, J., Vaccarino, V. Serotonin Transporter Gene, Depressive Symptoms, and Interleukin-6. Circulation-Cardiovascular Genetics 2(6): 614-U205, Su, S. Y., Zhao, J. Y., Bremner, J. D., Miller, A. H., Tang, W. N., Bouzyk, M., Snieder, H., Novik, O., Afzal, N., Goldberg, J., Vaccarino, V. Serotonin Transporter Gene, Depressive Symptoms, and Interleukin-6. Circulation-Cardiovascular Genetics 2(6): 614-U205, Su, S. Y., Lampert, R., Zhao, J. Y., Bremner, J. D., Miller, A., Snieder, H., Lee, F., Khan, D., Goldberg, J., Vaccarino, V. Pleiotropy of C- Reactive Protein Gene Polymorphisms With C-Reactive Protein Levels and Heart Rate Variability in Healthy Male Twins. American Journal of Cardiology 104(12): , Tan, E. S., Jessurun, G. A. J., Anthonio, R. L., Slart, R. H. J. A., Zijlstra, F., Tio, R. A. Electromechanical mapping of the left ventricle: 15

16 possible tool for online decision making in the catheterization laboratory. Journal of Cardiovascular Medicine 10(5): , Tan, E. S., Mulder, B. A., Rienstra, M., Wiesfeld, A. C. P., Ahmed, S., Zijlstra, F., van Gelder, I. C. Pulmonary vein isolation of symptomatic refractory paroxysmal and persistent atrial fibrillation A single centre and single operator experience in the Netherlands. Netherlands Heart Journal 17(10): , Teerlink, J. R., Metra, M., Felker, G. M., Ponikowski, P., Voors, A. A., Weatherley, B. D., Marmor, A., Katz, A., Grzybowski, J., Unemori, E., Teichman, S. L., Cotter, G. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373(9673): , Teichman, S. L., Unemori, E., Dschietzig, T., Conrad, K., Voors, A. A., Teerlink, J. R., Felker, G. M., Metra, M., Cotter, G. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart Failure Reviews 14(4): , Tio, R. A., Dabeshlim, A., Siebelink, H. M. J., de Sutter, J., Hillege, H. L., Zeebregts, C. J., Dierckx, R. A. J. O., van Veldhuisen, D. J., Zijlstra, F., Slart, R. H. J. A. Comparison Between the Prognostic Value of Left Ventricular Function and Myocardial Perfusion Reserve in Patients with Ischemic Heart Disease. Journal of Nuclear Medicine 50(2): , Tio, R. A., Slart, R. H. J. A., de Boer, R. A., van der Vleuten, P. A., de Jong, R. M., van Wijk, L. M., Willems, T., Lubbers, D. D., Voors, A. A., van Veldhuisen, D. J. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy. Netherlands Heart Journal 17(12): , Ulu, N., Henning, R. H., Goris, M., Schoeinaker, R. G., van Gilst, W. H. Effects of Ivabradine and Metoprolol on Cardiac Angiogenesis and Endothelial Dysfunction in Rats With Heart Failure. Journal of Cardiovascular Pharmacology 53(1): 9-17, Ulu, N., Schoemaker, R. G., Henning, R. H., Buikema, H., Teerlink, T., Zijlstra, F. J., Bakker, S. J. L., van Gilst, W. H., Navis, G. Proteinuria-Associated Endothelial Dysfunction Is Strain Dependent. American Journal of Nephrology 30(3): , van den Berg, M. P., de Boer, R. A., van Tintelen, J. P. Brugada Syndrome or Brugada Electrocardiogram? Journal of the American College of Cardiology 53(17): 1569, van der Meer, P., van Veldhuisen, D. J. Anaemia and renal dysfunction in chronic heart failure. Heart 95(21): , van der Meer, P., Groenveld, H. F., Januzzi, J. L., van Veldhuisen, D. J. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 95(16): , van der Meer, P., van Veldhuisen, D. J. Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure Reply. Heart 95(15): 1279, van der Meer, P., van Veldhuisen, D. J. The authors' reply. Heart 95(15): 1279, van der Roest, W. P., Pennings, J. M., Bakker, M., van den Berg, M. P., van Tintelen, J. P. Family Letters Are an Effective Way to Inform Relatives About Inherited Cardiac Disease. American Journal of Medical Genetics Part A 149A(3): , van der Vleuten, P. A., de Jonge, G. J., Lubbers, D. D., Tio, R. A., Willems, T. P., Oudkerk, M., Zijlstra, F. Evaluation of global left ventricular function assessment by dual-source computed tomography compared with MRI. European Radiology 19(2): , van der Vleuten, P. A., Vogelzang, M., Svilaas, T., van der Horst, I. C. C., Tio, R. A., Zijlstra, F. Predictive value of Q waves on the 12- lead electrocardiogram after reperfusion therapy for ST elevation myocardial infarction. Journal of Electrocardiology 42(4): , van der Wall, E. E., de Boer, M. J., Doevendans, P. A., Wilde, A. A., Zijlstra, F. Major achievements in cardiology in the past century: influence on Dutch cardiovascular medicine. Netherlands Heart Journal 17(4): , van der Zwaag, P. A., Jongbloed, J. D. H., van den Berg, M. P., van der Smagt, J. J., Jongbloed, R., Bikker, H., Hofstra, R. M. W., van Tintelen, J. P. A Genetic Variants Database for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Human Mutation 30(9): , van der Zwaag, P. A., Jongbloed, J. D. H., van den Berg, M. P., Jonkman, M. F., van Tintelen, J. P. Letter regarding the article: "R298Q mutation of p63 gene in autosomal dominant ectodermal dysplasia associated with arrhythmogenic right ventricular cardiomyopathy" by Valenzise et al. European Journal of Medical Genetics 52(4): 277, van Loon, R. L. E., Roofthooft, M. T. R., van Osch-Gevers, M., Delhaas, T., Strengers, J. L. M., Blom, N. A., Backx, A., Berger, R. M. F. Clinical Characterization of Pediatric Pulmonary Hypertension: Complex Presentation and Diagnosis. Journal of Pediatrics 155(2): , van Tintelen, J. P., Hauer, R. N. W. New test for arrhythmogenic right ventricular cardiomyopathy. Nature Reviews Cardiology 6(7): , van Tintelen, J. P., van Gelder, I. C., Asimaki, A., Suurmijer, A. J. H., Wiesfeld, A. C. P., Jongbloed, J. D. H., van den Wijngaard, A., 16

17 Kuks, J. B. M., Van Spaendonck-Zwarts, K. Y., Notermans, N., Boven, L., van den Heuvel, F., Veenstra-Knol, H. E., Saffitz, J. E., Hofstra, R. M. W., van den Berg, M. P. Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm 6(11): , van Veldhuisen, D. J., Cohen-Solal, A., Bohm, M., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J. S., Poole-Wilson, P. A., Flather, M. D. Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). Journal of the American College of Cardiology 53(23): , van Veldhuisen, D. J., Maass, A. H., Priori, S. G., Stolt, P., van Gelder, I. C., Dickstein, K., Swedberg, K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to European Journal of Heart Failure 11(12): , van Veldhuisen, D. J., de Boer, R. A. Low-dose digoxin in heart failure. International Journal of Cardiology 136(1): 90-91, Vis, J. C., Thoonsen, H., Duffels, M. G., de Bruin-Bon, R. A., Huisman, S. A., van Dijk, A. P., Hoendermis, E. S., Berger, R. M., Bouma, B. J., Mulder, B. J. Six-Minute Walk Test in Patients With Down Syndrome: Validity and Reproducibility. Archives of Physical Medicine and Rehabilitation 90(8): , Vlaar, P. J., Zijlstra, F. Angiographic Restenosis and Clinical Recurrence After Sirolimus- and Paclitaxel-Eluting Stent Implantation. JACC: Cardiovascular Interventions 2(8): , Vlaar, P. J., Svilaas, T., Damman, K., de Smet, B. J. G. L., Hillege, H. L., Zijlstra, F., Tijssen, J. G. P. Response to Letter Regarding Article, "Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review. Circulation 120(4): E27, Vlaar, P. J., Zijlstra, F. Angiographic Restenosis and Clinical Recurrence After Sirolimus- and Paclitaxel-Eluting Stent Implantation. JACC: Cardiovascular Interventions 2(8): , Vogelzang, M., Vlaar, P. J., Svilaas, T., Amo, D., Nijsten, M. W. N., Zijlstra, F. Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial. European Heart Journal 30(5): , Voors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. European Heart Journal 30(10): , Wang, X., Ding, X., Su, S., Spector, T. D., Mangino, M., Iliadou, A., Snieder, H. Heritability of insulin sensitivity and lipid profile depend on BMI: evidence for gene-obesity interaction. Diabetologia 52(12): , Wang, X. L., Ding, X. H., Su, S. Y., Yan, W. L., Harshfield, G., Treiber, F., Snieder, H. Genetic influences on daytime and night-time blood pressure: similarities and differences. Journal of Hypertension 27(12): , Wang, X. L., Ding, X. H., Su, S. Y., Li, Z. B., Riese, H., Thayer, J. F., Treiber, F., Snieder, H. Genetic influences on heart rate variability at rest and during stress. Psychophysiology 46(3): , Westendorp, B., Hamming, I., Szymanski, M. K., Navis, G., van Goor, H., Buikema, H., van Gilst, W. H., Schoemaker, R. G. Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor. European Journal of Pharmacology 602(2-3): , Willemsen, H. M., de Jong, G., Tio, R. A., Nieuwland, W., Kema, I. P., van der Horst, I. C. C., Oudkerk, M., Zijlstra, F. Quick identification of acute chest pain patients study (QICS). BMC Cardiovascular Disorders 9 AR 24 DI / Willemsen, H. M., van der Horst, I. C. C., Nieuwland, W., Slart, R. J. H. A., Zeebregts, C. J., de Boef, E., Schuitemaker, J. H. N., Zijlstra, F., Tio, R. A. The diagnostic value of soluble CD163 in patients presenting with chest pain. Clinical Biochemistry 42(16-17): , Winter, M. M., Bouma, B. J., Groenink, M., Konings, T. C., Tijssen, J. G. P., van Veldhuisen, D. J., Mulder, B. J. M. Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart 95(12): , Wong, L. S., Windt, W. A., Roks, A. J., van Dokkum, R. P., Schoemaker, R. G., de Zeeuw, D., Henning, R. H. Renal failure induces telomere shortening in the rat heart. Netherlands Heart Journal 17(5): , Wong, L. S. M., van der Harst, P., de Boer, R. A., Codd, V., Huzen, J., Samani, N. J., Hillege, H. L., Voors, A. A., van Gilst, W. H., Jaarsma, T., van Veldhuisen, D. J. Renal dysfunction is associated with shorter telomere length in heart failure. Clinical Research in Cardiology 98(10): , Wong, L. S. M., Oeseburg, H., de Boer, R. A., van Gilst, W. H., van Veldhuisen, D. J., van der Harst, P. Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. Cardiovascular Research 81(2): , 17

18 Xu, Y., Henning, R. H., Sandovici, M., van der Want, J. J., van Gilst, W. H., Buikema, H. Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT(1)- and epidermal growth factor-receptor function. European Journal of Heart Failure 11(3): , Yap, S. C., Drenthen, W., Meijboom, F. J., Moons, P., Mulder, B. J. M., Vliegen, H. W., van Dijk, A. P. J., Jaddoe, V. W. V., Steegers, E. A. P., Roos-Hesselink, J. W., Pieper, P. G. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. Bjog - an International Journal of Obstetrics and Gynaecology 116(12): , 18

19 GRONINGEN RESEARCH INSTITUTE FOR ASTHMA AND COPD - GRIAC Dissertaties Abello, N. J-R. Chemical labeling for the analysis of proteins, peptides and metabolites by mass spectroscopy. (2009) Bischoff, R. P. H. and Postma, D. S. Brusse-Keizer, M. G. J. COPD excacerbations. Treatment and outcome. (2009) van der Palen, J. and Kerstjens, H. A. M. Dijkstra, A. Lung function impairment in asthma : contributing risk factors and gene polymorphisms. (2009) Postma, D. S., Timens, W., ten Hacken, N. H. T., and Vonk, J. M. Flokstra-de Blok, B. M. J. Development, valdidation and outcome of health-related quality of life questionnairies for food allergic patients. (2009) Dubois, A. E. J., Duiverman, E. J., and Vlieg- Boerstra, B. J. Oude Elberink, H. Quality of Life in Insect venom allergy. (2009) Dubois, A. E. J. and de Monchy, J. G. R. Reijmerink, N. E. A Search for missing pieces of the puzzle; the development of asthma and atopy. (2009) Postma, D. S., Brunekreef, B., Koppelman, G. H., Kerkhof, M., and Gerritsen, J. Siedlinski, M. I. Genetic and environmental determinants of lung function in the general population. (2009) Boezen, H. M., Postma, D. S., and Smit, H. A. van der Toorn, M. Cigarette smoke-induced mitochondrial dysfunction and oxidative stress in. (2009) Kauffman, H. F., Gans, R. O. B., Koëter, G. H., Slebos, D. J., and Bakker, S. J. L. Journal articles Barton, S. J., Koppelman, G. H., Vonk, J. M., Browning, C. A., Nolte, I. M., Stewart, C. E., Bainbridge, S., Mutch, S., Rose-Zerilli, M. J., Postma, D. S., Maniatis, N., Henry, A. P., Hall, I. P., Holgate, S. T., Tighe, P., Holloway, J. W., Sayers, I. PLAUR polymorphisms are associated with asthma, PLAUR levels, and lung function decline. Journal of Allergy and Clinical Immunology 123(6): , Bateman, E. D., Rennard, S., Barnes, P. J., Dicpinigaitis, P. V., Gosens, R., Gross, N. J., Nadel, J. A., Pfeifer, M., Racke, K., Rabe, K. F., Rubin, B. K., Welte, T., Wessler, I. Alternative mechanisms for tiotropium. Pulmonary Pharmacology & Therapeutics 22(6): , Bathoorn, E., Liesker, J. J. W., Postma, D. S., Koeter, G. H., van der Toorn, M., van der Heide, S., Ross, H. A., van Oosterhout, A. J. M., Kerstjens, H. A. M. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. International Journal of COPD 4(1): , Blacquiere, M. J., Timens, W., Melgert, B. N., Geerlings, M., Postma, D. S., Hylkema, M. N. Maternal smoking during pregnancy induces airway remodelling in mice offspring. European Respiratory Journal 33(5): , Boelens, M. C., van den Berg, A., Fehrmann, R. S. N., Geerlings, M., de Jong, W. K., Meerman, G. J. T., Sietsma, H., Timens, W., Postma, D. S., Groen, H. J. M. Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer. Journal of Pathology 218(2): , Boelens, M. C., Kok, K., van der Vlies, P., van der Vries, G., Sietsma, H., Timens, W., Postma, D. S., Groen, H. J. M., van den Berg, A. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. Lung Cancer 66(3): , Boezen, H. M. Genome-wide association studies: What do they teach us about asthma and chronic obstructive pulmonary disease? Proceedings of the American Thoracic Society 6(8): , Bossenbrock, L., ten Thicken, N. H. T., van der Bij, W., Verschuuren, E. A. M., Koeter, G. H., de Greef, M. H. G. Cross-sectional Assessment of Daily Physical Activity in Chronic Obstructive Pulmonary Disease Lung Transplant Patients. Journal of Heart and Lung Transplantation 28(2): , Brandsma, C. A., Hylkema, M. N., Geerlings, M., van Geffen, W. H., Postma, D. S., Timens, W., Kerstjens, H. A. M. Increased levels of (class switched) memory B cells in peripheral blood of current smokers. Respiratory Research 10 AR 108 DI / Broekema, M., ten Hacken, N. H. T., Volbeda, F., Lodewijk, M. E., Hylkema, M. N., Postma, D. S., Timens, W. Airway Epithelial Changes in Smokers but Not in Ex-Smokers with Asthma. American Journal of Respiratory and Critical Care Medicine 180(12): , Broekema, M., ten Hacken, N. H. T., Volbeda, F., Lodewijk, M. E., Hylkema, M. N., Postma, D. S., Timens, W. Airway Epithelial Changes in Smokers but Not in Ex-Smokers with Asthma. 19

20 American Journal of Respiratory and Critical Care Medicine 180(12): , Brugemann, J., van der Bij, W., Verschuuren, E. A. M., Klungel, A. A., van der Horst, I. C. C., Erasmus, M. E., Kerstjens, H. A. M., van Veldhuisen, D. J., Zijlstra, F. Experience with combined heartlung transplant at the University Medical Center Groningen. Nederlands Tijdschrift voor Geneeskunde 153(27): , Brusselle, G. G., Demoor, T., Bracke, K. R., Brandsma, C. A., Timens, W. Lymphoid follicles in (very) severe COPD: beneficial or harmful? European Respiratory Journal 34(1): , Camp, P. G., O'Donnell, D. E., Postma, D. S. Chronic obstructive pulmonary disease in men and women: Myths and reality. Proceedings of the American Thoracic Society 6(6): , Caudri, D., Wijga, A., Scholtens, S., Kerkhof, M., Gerritsen, J., Ruskamp, J. M., Brunekreef, B., Smit, H. A., de Jongste, J. C. Early Daycare Is Associated with an Increase in Airway Symptoms in Early Childhood but Is No Protection against Asthma or Atopy at 8 Years. American Journal of Respiratory and Critical Care Medicine 180(6): , Caudri, D., Wijga, A., Schipper, C. M. A., Hoekstra, M., Postma, D. S., Koppelman, G. H., Brunekreef, B., Smit, H. A., de Jongste, J. C. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. Journal of Allergy and Clinical Immunology 124(5): , Cerveri, I., Corsico, A. G., Accordini, S., Cervio, G., Ansaldo, E., Grosso, A., Niniano, R., Tegomo, E. T., Anto, J. M., Kunzli, N., Janson, C., Sunyer, J., Svanes, C., Heinrich, J., Schouten, J. P., Wjst, M., Pozzi, E., de Marco, R. What defines airflow obstruction in asthma? European Respiratory Journal 34(3): , Dekkers, B. G. J., Schaafsma, D., Tran, T., Zaagsma, J., Meurs, H. Insulin-Induced Laminin Expression Promotes a Hypercontractile Airway Smooth Muscle Phenotype. American Journal of Respiratory Cell and Molecular Biology 41(4): , Dijkstra, A., Postma, D. S., Noordhoek, J. A., Lodewijk, M. E., Kauffman, H. F., ten Hacken, N. H. T., Timens, W. Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung. Virchows Archiv 454(4): , Duiverman, M. L., de Boer, E. W. J., van Eykern, L. A., de Greef, M. H. G., Jansen, D. F., Wempe, J. B., Kerstjens, H. A. M., Wijkstra, P. J. Respiratory muscle activity and dyspnea during exercise in chronic obstructive pulmonary disease. Respiratory Physiology & Neurobiology 167(2): , DunnGalvin, A., Chang, W. C., Laubach, S., Steele, P. H., Dubois, A. E. J., Burks, A. W., Hourihane, J. O. Profiling Families Enrolled in Food Allergy Immunotherapy Studies. Pediatrics 124(3): E503- E509, Effing, T., Kerstjens, H., van der Valk, P., Zielhuis, G., van der Palen, J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 64(11): , Effing, T. W., Kerstjens, H. A. M., Monninkhof, E. M., van der Valk, P. D. L. P., Wouters, E. F. M., Postma, D. S., Zielhuis, G. A., van der Palen, J. Definitions of Exacerbations Does It Really Matter in Clinical Trials on COPD? Chest 136(3): , Flokstra-de Blok, B. M. J., van der Meulen, G. N., DunnGalvin, A., Vlieg-Boerstra, B. J., Elberink, J. N. G. O., Duiverman, E. J., Hourihane, J. O., Dubois, A. E. J. Development and validation of the Food Allergy Quality of Life Questionnaire - Adult Form. Allergy 64(8): , Flokstra-de Blok, B. M. J., DunnGalvin, A., Vlieg-Boerstra, B. J., Oude Elberink, J. N. G., Duiverman, E. J., Hourihane, J. O., Dubois, A. E. J. Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children. Clinical and Experimental Allergy 39(1): , Flokstra-de Blok, B. M. J., Oude Elberink, J. N. G., Vlieg-Boerstra, B. J., Duiverman, E. J., Dubois, A. E. J. Measuring health-related quality of life: Fundamental methodological issues. Clinical and Experimental Allergy 39(11): 1774, Flokstra-de Blok, B. M. J., Dubois, A. E. J. Quality of life in food allergy: valid scales for children and adults. Current Opinion in Allergy and Clinical Immunology 9(3): , Gehring, U., Oldenwening, M., Brunekreef, B., Wieringa, M. H., Kerkhof, M., Smit, H. A., van der Ent, C. K., de Jongste, J. C. The impact of ambient NO on online measurements of exhaled and nasal NO: The PIAMA study. Pediatric Allergy and Immunology 20(7): , Gerritsen, J. The Brussels Declaration. European Respiratory Journal 34(1): 290, Gkoumassi, E., Dekkers, B. G. J., Droge, M. J., Elzinga, C. R. S., Hasenbosch, R. E., Meurs, H., Nelemans, S. A., Schmidt, M., Zaagsma, J. (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells. Naunyn- Schmiedebergs Archives of Pharmacology 380(1): 67-77, Goossens, L. M. A., Riemersma, R. A., Postma, D. S., van der Molen, T., Rutten-van Molken, M. P. M. H. An Economic Evaluation of Budesonide/Formoterol for Maintenance and Reliever Treatment in Asthma in General Practice. Advances in Therapy 26(9): , Gosens, R., Rieks, D., Meurs, H., Ninaber, D. K., Rabe, K. F., Nanninga, J., Kolahian, S., Halayko, A. J., Hiemstra, P. S., Zuyderduyn, S. Muscarinic M3 receptor stimulation increases 20

1. Bruggink-André de la Porte PWF ISBN : 978-90-902-3824-1 Effects of heart failure management programmes Promotiedatum: 16 januari 2009

1. Bruggink-André de la Porte PWF ISBN : 978-90-902-3824-1 Effects of heart failure management programmes Promotiedatum: 16 januari 2009 Publicaties 2009 Dissertaties 2009 1. Bruggink-André de la Porte PWF ISBN : 978-90-902-3824-1 Effects of heart failure management programmes Promotiedatum: 16 januari 2009 Promotores: Prof.dr. A.W. Hoes

More information

Annual Publication Report

Annual Publication Report Annual Publication Report 2008 TABLE OF CONTENTS 3 GRONINGEN INSTITUTE FOR KIDNEY DISEASES GIKD 8 CARDIOVASCULAR CENTER CVC 16 INSTITUTE FOR PHARMACOEPIDEMIOLOGY AND DRUG POLICY PEDP 20 GRONINGEN RESEARCH

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

WETENSCHAPPELIJKE OUTPUT THORAXCENTRUM UMCG, 2008

WETENSCHAPPELIJKE OUTPUT THORAXCENTRUM UMCG, 2008 WETENSCHAPPELIJKE OUTPUT THORAXCENTRUM UMCG, 2008 Dissertaties 1. Geluk CA Coronary risk stratification. From PREVEND to the prevention of coronary events. ISBN: 978-90-367-3258-1 Promotiedatum: 16 januari

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

Understanding diabetes Do the recent trials help?

Understanding diabetes Do the recent trials help? Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized

More information

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary

More information

Rudolf de Boer. Paula Da Costa Martins. Ralph van Oort. Kevin Vernooij. Daniël Pijnappels. Lynda Juffermans. Toon van Veen. Peter van der Meer

Rudolf de Boer. Paula Da Costa Martins. Ralph van Oort. Kevin Vernooij. Daniël Pijnappels. Lynda Juffermans. Toon van Veen. Peter van der Meer Paula Da Costa Martins Ralph van Oort Lynda Juffermans Kevin Vernooij Daniël Pijnappels Toon van Veen Rudolf de Boer Linda van Laake Kim Van der Heiden Matthijs Boekholdt Peter van der Meer Blanche Schroen

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

Drug Treatment in Type 2 Diabetes with Hypertension

Drug Treatment in Type 2 Diabetes with Hypertension Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

Introduction. Pathogenesis of type 2 diabetes

Introduction. Pathogenesis of type 2 diabetes Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic

More information

R EFERENCES. Summary and conclusions

R EFERENCES. Summary and conclusions R EFERENCES Summary and conclusions 129 S UMMARY AND CONCLUSIONS SUMMARY AND GENERAL DISCUSSION 130 Constant vasodilatation, inhibition of platelet and monocyte adhesion, and local thrombolysis are the

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

In many diabetes units, people with type

In many diabetes units, people with type Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for

More information

InDependent Diabetes Trust

InDependent Diabetes Trust InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use

More information

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

25-hydroxyvitamin D: from bone and mineral to general health marker

25-hydroxyvitamin D: from bone and mineral to general health marker DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate

More information

Diabetes and the Kidneys

Diabetes and the Kidneys Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

Elenco dei periodici elettronici in Ovid Full text

Elenco dei periodici elettronici in Ovid Full text Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders

More information

Diagnostic and Therapeutic Procedures

Diagnostic and Therapeutic Procedures Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,

More information

Annual Publication Report 2010

Annual Publication Report 2010 Annual Publication Report 2010 TABLE OF CONTENTS 2 GRONINGEN INSTITUTE FOR KIDNEY DISEASES GIKD 8 CARDIOVASCULAR CENTER CVC 18 GRONINGEN RESEARCH INSTITUTE FOR ASTHMA AND COPD GRIAC 24 CENTER FOR LIVER,

More information

1. Geluk CA Coronary risk stratification. From PREVEND to the prevention of coronary events. ISBN: 978-90-367-3258-1 Promotiedatum: 16 januari 2008

1. Geluk CA Coronary risk stratification. From PREVEND to the prevention of coronary events. ISBN: 978-90-367-3258-1 Promotiedatum: 16 januari 2008 PUBLICATIES 2008 Dissertaties 1. Geluk CA Coronary risk stratification. From PREVEND to the prevention of coronary events. ISBN: 978-90-367-3258-1 Promotiedatum: 16 januari 2008 Promotores: Prof.dr. F.

More information

Microalbuminuria: An increasingly recognized risk factor for CVD

Microalbuminuria: An increasingly recognized risk factor for CVD Microalbuminuria: An increasingly recognized risk factor for CVD Long known to be associated with kidney disease, the importance of protein in the urine is now becoming recognized as a sensitive, accessible

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss

More information

Advanced Heart Failure & Transplantation Fellowship Program

Advanced Heart Failure & Transplantation Fellowship Program Advanced Heart Failure & Transplantation Fellowship Program Curriculum I. Patient Care When on the inpatient Heart Failure and Transplant Cardiology service, the cardiology fellow will hold primary responsibility

More information

How To Know If Low Protein Diet Is Beneficial For Kidney Health

How To Know If Low Protein Diet Is Beneficial For Kidney Health Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use London, 25 September 2008 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE

More information

Subject Index. Bariatric surgery, obesity management 134

Subject Index. Bariatric surgery, obesity management 134 Subject Index Acromegaly, PCOS differential diagnosis 149, 150, 154, 155 Adipokines, see specific adipokines Adiponectin, metabolic syndrome role 41 43 Adolescents, PCOS diagnosis 16, 17 Adrenal hyperplasia,

More information

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency London, 19 July 2007 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR

More information

INTRODUCTION TO EECP THERAPY

INTRODUCTION TO EECP THERAPY INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and

More information

ACLS PHARMACOLOGY 2011 Guidelines

ACLS PHARMACOLOGY 2011 Guidelines ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.

More information

Innovation Platform: Sudden Cardiac Death

Innovation Platform: Sudden Cardiac Death Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration

More information

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Drugs for the treatment of Remit / Appraisal objective: Final scope To appraise the clinical and cost effectiveness of

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE

More information

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA 1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate

More information

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care Transplant Journey Lynette Fix, RN, BAN, CCTC Objectives Identify key components of transplant evaluation process Identify the patient follow-up process Describe diseases indicated for transplantation

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary

More information

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges NAME Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges GENERAL CARDIOLOGY Required Qualifications for General Cardiology Education/Training/Experience Must have

More information

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.

More information

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long

More information

A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation

A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation Gabriel Sayer Lay Abstract: Atrial fibrillation is a common form of irregular,

More information

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

1 Congestive Heart Failure & its Pharmacological Management

1 Congestive Heart Failure & its Pharmacological Management Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructor: Prof. Keith Baker 1 Congestive Heart Failure & its Pharmacological Management Keith Baker, M.D., Ph.D.

More information

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Behçet s Disease and the Kidneys How are the kidneys affected by Behçet s disease? Kidney disease

More information

CARDIAC CARE. Giving you every advantage

CARDIAC CARE. Giving you every advantage CARDIAC CARE Giving you every advantage Getting to the heart of the matter The Cardiovascular Program at Northwest Hospital & Medical Center is dedicated to the management of cardiovascular disease. The

More information

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)

More information

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D. TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type

More information

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae Ariela Benigni Biol.Sci.D., Ph.D. Curriculum Vitae Personal Data Name: Date and place of birth: Citizenship: E-mail: Ariela Benigni December 16, 1955 - Bergamo, Italy Italian ariela.benigni@marionegri.it

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing

More information

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc. PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent

More information

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

BSc in Medical Sciences with PHARMACOLOGY

BSc in Medical Sciences with PHARMACOLOGY BSc in Medical Sciences with PHARMACOLOGY Course Director Dr Christopher John Module Leaders Dr Robert Dickinson (Module 1) Dr Anabel Varela Carver (Module 2) Dr Sohag Saleh (Module 3) Course Administrator

More information

Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy

Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Risk Factors of chronic complex co-morbidities Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Statement 1 In real world practice (and in clinical trials), complex co-morbidities are the

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY 1. SCOPE AND METHODOLOGY 2. REPORT SYNOPSIS 2.1 General Definitions Myoblasts Pluripotent Cells Multipotent Cells Progenitor Cells Role of Stem Cells in Repairing the Heart Stem Cell Therapy Stem Cells

More information

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:

More information

Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias

Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias Cardiovascular System & Its Diseases Lecture #4 Heart Failure & Cardiac Arrhythmias Dr. Derek Bowie, Department of Pharmacology & Therapeutics, Room 1317, McIntyre Bldg, McGill University derek.bowie@mcgill.ca

More information

Diabetes mellitus. Lecture Outline

Diabetes mellitus. Lecture Outline Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized

More information

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:

More information

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

The new Heart Failure pathway

The new Heart Failure pathway The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising

More information

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is

More information

Renovascular Hypertension

Renovascular Hypertension Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension

More information

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department

More information

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University

More information